Sign in
4

Changes in Ownership

Protagenic Therapeutics, Inc.new Filed Acc 0001493152-20-003033

Options or other derivatives

  • Chief Financial Officer acquired 307,497 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Arrow Alexander K. Chief Financial Officer 2020-02-21 Grant or award · PTIX Common stock Options +307,497 307,497 D
Loading xslF345X03/ownership.xml…